French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. Founded out of Paris in 2019, recent Y Combinator (YC) graduate WhiteLab Genomics provide gene and cell therapy companies with predictive software simulations to expedite the design of gene and […]
How WhiteLab Genomics is using AI to aid gene and cell therapy development by Paul Sawers originally published on TechCrunch...